SNS Financial Group’s AbbVie ABBV Stock Holding History

SNS Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.82M	Sell	12,988 -17	-0.1%	-$3.77K	0.24%	44
2025 Q4	$2.97M	Buy	13,005 +5,767	+80%	+$1.31M	0.26%	40
2025 Q3	$1.68M	Buy	7,238 +19	+0.3%	+$3.87K	0.15%	59
2025 Q2	$1.34M	Sell	7,219 -8	-0.1%	-$1.49K	0.13%	68
2025 Q1	$1.51M	Sell	7,227 -35	-0.5%	-$6.8K	0.15%	62
2024 Q4	$1.29M	Sell	7,262 -116	-2%	-$21.3K	0.13%	73
2024 Q3	$1.46M	Buy	7,378 +32	+0.4%	+$5.97K	0.15%	67
2024 Q2	$1.26M	Buy	7,346 +41	+0.6%	+$6.79K	0.14%	74
2024 Q1	$1.33M	Buy	7,305 +60	+0.8%	+$10.3K	0.15%	76
2023 Q4	$1.12M	Sell	7,245 -268	-4%	-$39.1K	0.13%	75
2023 Q3	$1.12M	Buy	7,513 +75	+1%	+$11K	0.15%	69
2023 Q2	$1M	Sell	7,438 -121	-2%	-$17.7K	0.13%	79
2023 Q1	$1.2M	Sell	7,559 -2,722	-26%	-$416K	0.16%	73
2022 Q4	$1.66M	Buy	10,281 +262	+3%	+$40.2K	0.22%	58
2022 Q3	$1.34M	Buy	10,019 +43	+0.4%	+$6.17K	0.19%	70
2022 Q2	$1.53M	Sell	9,976 -92	-0.9%	-$14.1K	0.2%	66
2022 Q1	$1.63M	Sell	10,068 -222	-2%	-$32.2K	0.18%	74
2021 Q4	$1.39M	Sell	10,290 -117	-1%	-$13.8K	0.15%	89
2021 Q3	$1.12M	Buy	10,407 +2	+0%	+$229	0.13%	90
2021 Q2	$1.17M	Buy	10,405 +128	+1%	+$14.4K	0.15%	85
2021 Q1	$1.11M	Buy	10,277 +1,480	+17%	+$158K	0.15%	85
2020 Q4	$943K	Sell	8,797 -277	-3%	-$26.6K	0.14%	86
2020 Q3	$795K	Buy	9,074 +1	+0%	+$94	0.12%	96
2020 Q2	$890K	Buy	9,073 +283	+3%	+$24.9K	0.16%	85
2020 Q1	$670K	Buy	8,790 +2	+0%	+$170	0.13%	111
2019 Q4	$778K	Sell	8,788 -48	-0.5%	-$3.98K	0.14%	102
2019 Q3	$669K	Sell	8,836 -461	-5%	-$31.6K	0.13%	96
2019 Q2	$676K	Sell	9,297 -19	-0.2%	-$1.49K	0.13%	97
2019 Q1	$751K	Sell	9,316 -49	-0.5%	-$4.01K	0.17%	88
2018 Q4	$863K	Buy	9,365 +1	+0%	+$88	0.21%	83
2018 Q3	$886K	Sell	9,364 -64	-0.7%	-$6.07K	0.21%	77
2018 Q2	$873K	Sell	9,428 -2,572	-21%	-$251K	0.23%	67
2018 Q1	$1.14M	Sell	12,000 -1,024	-8%	-$112K	0.31%	59
2017 Q4	$1.26M	Sell	13,024 -52,018	-80%	-$4.9M	0.3%	61
2017 Q3	$5.78M	Sell	65,042 -6,282	-9%	-$478K	1.48%	18
2017 Q2	$5.17M	Sell	71,324 -6,104	-8%	-$410K	1.37%	18
2017 Q1	$5.04M	Sell	77,428 -47,136	-38%	-$2.96M	1.3%	20
2016 Q4	$7.8M	Buy	124,564 +22,112	+22%	+$1.35M	2.29%	9
2016 Q3	$6.46M	Buy	102,452 +12,171	+13%	+$788K	1.87%	12
2016 Q2	$5.59M	Buy	90,281 +79,320	+724%	+$4.83M	1.4%	13
2016 Q1	$626K	Buy	10,961 +200	+2%	+$11.1K	0.16%	70
2015 Q4	$637K	Buy	10,761 +446	+4%	+$25.7K	0.16%	71
2015 Q3	$561K	Sell	10,315 -44	-0.4%	-$2.86K	0.15%	75
2015 Q2	$696K	Sell	10,359 -975	-9%	-$63.7K	0.21%	66
2015 Q1	$663K	Buy	11,334 +1,052	+10%	+$63.6K	0.24%	64
2014 Q4	$673K	Sell	10,282 -139	-1%	-$8.76K	0.27%	63
2014 Q3	$602K	Buy	10,421 +631	+6%	+$35K	0.2%	65
2014 Q2	$553K	Buy	+9,790	New	+$514K	0.22%	64
2014 Q1	–	Sell	-15,422	Closed	-$814K	–	86
2013 Q4	$814K	Buy	15,422 +2,700	+21%	+$133K	0.38%	53
2013 Q3	$569K	Buy	+12,722	New	+$564K	0.36%	51

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SNS Financial Group's ABBV Position: Q1 2026 in Review

SNS Financial Group reduced its AbbVie (ABBV) stake by 0.13% in Q1 2026, selling an estimated $3.77K and leaving 12,988 shares worth $2.82M. The position accounts for 0.24% of the portfolio, ranked #44.

SNS Financial Group first reported a position in ABBV in Q3 2013 and has held it in 50 quarters since. The position peaked at $7.8M in Q4 2016. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

SNS Financial Group held 12,988 shares of AbbVie worth $2.82M as of Q1 2026.
SNS Financial Group sold 17 AbbVie shares in Q1 2026, an estimated $3.77K.
AbbVie made up 0.24% of SNS Financial Group's portfolio in Q1 2026, its #44 holding.
SNS Financial Group first reported a position in AbbVie in Q3 2013 and has held it in 50 quarters since.
SNS Financial Group's AbbVie position peaked at $7.8M in Q4 2016.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SNS Financial Group's 13F filing for Q1 2026, filed 14 Apr 2026.